Andrea Charles | 06/06/2011
The lengthy clinical development process of drug development for life threatening diseases is not an optimal development strategy for oncology therapeutic area. Adaptive designs have become popular tools in oncology research, helping to achieve validity, efficiency and speed in clinical development. In this interview Surya Chitra, PhD, MBA, Biostatistics and Pharmacology, and Gary Fishbein, MD, MPH, Senior Medical Director, PharmaNet Development Group, Inc., join Andrea Charles from Pharma IQ to...
To continue reading this story Click Here
RECOMMENDED
Upcoming Events
SmartLab Exchange Europe
February 25 - 26, 2025
Novotel Amsterdam City, Netherlands
Register Now |
View Agenda |
Learn More
SmartLab Exchange USA 2025
08 - 09 April, 2025
Le Méridien, Fort Lauderdale, Florida, USA
Register Now |
View Agenda |
Learn More